Literature DB >> 10079808

Miller Fisher syndrome with central involvement: successful treatment with plasmapheresis.

J H Yeh1, W H Chen, J R Chen, H C Chiu.   

Abstract

Miller Fisher syndrome is characterized by external ophthalmoplegia, ataxia, and areflexia. Most researchers favor a peripheral origin while others suggest a brainstem inflammatory lesion or a combination of central and peripheral demyelination. We report 2 cases of Miller Fisher syndrome with the typical triad of ataxia, areflexia, and ophthalmoplegia. Strong clinical evidence of central involvement included initial drowsiness, bilateral Babinski sign, and quadriparesis. Evoked potential studies showed prolongation of central conduction time. Plasmapheresis was performed to relieve respiratory failure in Patient 1 and to shorten the duration of nasogastric tube feeding due to severe bulbar palsy in Patient 2. Significant improvement of electrophysiologic parameters was recorded after plasmapheresis. Abnormal evoked potentials, together with clinical evidence of central nervous system abnormalities, support the hypothesis that there is a combination of peripheral and central involvement in Miller Fisher syndrome in our patients. Plasmapheresis is highly effective in relieving the profound neurological deficits of this atypical syndrome.

Entities:  

Mesh:

Year:  1999        PMID: 10079808     DOI: 10.1046/j.1526-0968.1999.00104.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN: 1091-6660


  4 in total

1.  Acute bilateral ophthalmoparesis with pupilary areflexical mydriasis in miller-fisher syndrome treated with intravenous immunoglobulin.

Authors:  Theocharis Papanikolaou; Cath Gray; Bernard Boothman; Gerald Naylor; George Mariatos
Journal:  J Ophthalmol       Date:  2010-09-01       Impact factor: 1.909

2.  Ataxia, ophthalmoplegia, and areflexia: what would you think?

Authors:  N Karsan; P Fletcher; I Bodi; B K Macdonald
Journal:  Case Rep Neurol Med       Date:  2012-06-27

Review 3.  Anti-glutamic acid decarboxylase antibody positive neurological syndromes.

Authors:  Hassaan Tohid
Journal:  Neurosciences (Riyadh)       Date:  2016-07       Impact factor: 0.906

4.  Acute Bilateral External Ophthalmoplegia in Miller Fisher Syndrome.

Authors:  Feyza Calis Karanfil; Huban Atilla
Journal:  Beyoglu Eye J       Date:  2019-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.